The Efficacy and Safety of Leard- Ngam Remedy Powder versus Mefenamic Acid on Relieving Primary Dysmenorrhea

Phase 2

• Conditions: primary dysmenorrhea; Leard- Ngam, mefenamic acid, Primary dysmenorrhea

• Registration Number: TCTR20190114002
• Lead Sponsor: Center of Excellence in Applied Thai Traditional Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-07-06
• Study Start: 2019-01-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: Female
• Target Recruitment: 78

Inclusion Criteria

1. suffer from primary dysmenorrhea diagnosed by a gynecologist
2. have a regular menstrual cycle
3. require analgesic drug for relieving pain.
4. Volunteers must pass the screening criteria based on the questionnaire and have pain score not less than 3

Exclusion Criteria

1. pregnant or breast feeding
2. taking oral contraceptive medicine or contraceptive injections
for 6 months prior to enrollment.
3. having severe gastrointestinal, gynaecological, or autoimmune
diseases
4. have parturition, pregnant or abortion
5. receive gynaecological surgery within 1 year prior to the trial
6. have medicinal and herbal sensitivities

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Assessment Change form baseline at 7 months. every month (7 months) using NRS for evaluate patient’s menstrual pain.

Secondary Outcome Measures

Name	Time	Method
symptoms of menstruation every month (7 months) Using the menstrual symptom Questionnaire.